Nuclear Medicine/Radiopharmaceuticals Market in China : Share, Analysis, Market Forecast And Growth Research Report
The global nuclear
medicine/radiopharmaceuticals market is expected to reach US$ 6,683.99 Mn in
2027 from US$ 3,982.11 Mn in 2018.The market is estimated to grow with a CAGR
of 6.2% from 2019-2027.
The
market for nuclear medicine/radiopharmaceuticals is expected to grow, owing to
factors such as rising prevalence of chronic diseases, alpha
radioimmunotherapy-based targeted oncology treatment and advancement in imaging
technologies using radiopharmaceuticals play vital role in the growth of the
radiopharmaceuticals market. However, the restraints such as short shelf-life
of radiopharmaceuticals and availability of substitutes of radiopharmaceuticals
are likely to impact the growth of the market in the forecast period.
Get Sample PDF Of Nuclear
Medicine/Radiopharmaceuticals Market @
A
radiopharmaceutical is a drug, which can be used either for diagnostic or
therapeutic purposes. Radiopharmaceuticals are radioisotopes that are bound to
biological molecules that target specific tissues, organs, or cells within the
human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging
where the radiation escapes the body. These rays are detected by a specific
device, which is usually single-photon emission computed tomography (SPECT)/
positron emission tomography (PET) cameras.
The shelf-life or expiry date of a radiopharmaceutical preparation depends mainly on the half-life of the radioisotope, the radiochemical stability and the content of longer-lived radionuclide impurities in the preparation under consideration. Most of the radiopharmaceutical preparations contain radioisotopes with very short half-lives and such preparations have very short shelf-lives. These preparations require an expiry date and time to be indicated. For example, technetium based preparations and positron emission tomography (PET) preparations are generally intended to be used within less than 12 hours, or sometimes within few minutes of preparation. Hence, the short shelf-life of radiopharmaceuticals are expected to hinder the growth of the market in the future years.
Global nuclear medicine/radiopharmaceuticals were segmented by application and end user.
Ask For Discount @
The application segment was segmented as
diagnostic applications and therapeutic applications. Based on the end user,
the market was segmented as hospitals and diagnostic centers. During 2018, the
hospitals segment led the nuclear medicine/radiopharmaceuticals market by the
end user.
Some of the major primary and secondary sources included in the report for, Society of Nuclear Medicine, Food and Drug Administration, American Cancer Society, World Health Organization, American Hospital Association (AHA), National Cancer Institute (NCI), Canadian Association of Nuclear Medicine, and others.
Some of the major primary and secondary sources included in the report for, Society of Nuclear Medicine, Food and Drug Administration, American Cancer Society, World Health Organization, American Hospital Association (AHA), National Cancer Institute (NCI), Canadian Association of Nuclear Medicine, and others.
About Us :
Intelligence Market Research & Consulting, LLP (IMRC) is a
global provider of research reports, business intelligence & consulting
services. We know and understand the importance of market research data for
your institution. Therefore, we have teamed up with the leading research
institutes and strategy specialists to bring to you the latest, niche and most
relevant statistical research.
At IMRC, we have one of the most exhaustive, highly reliable
database of market research reports sourced from publishers and authors after a
thorough quality check and screening of the market study and credentials. We
have a team of key market experts who evaluate the market size, growth
prospects, end-use, applications, value & supply chain and top vendors in
the industry to help the clients to take most accurate and logical business
decisions without any vague assumptions.
Contact
Us:
699, Butler St. Suite 1007
Saugatuck, MI - 49453, United States.
Phone : +1 209
691 5657
Comments
Post a Comment